Search results for "TC"

showing 10 items of 9993 documents

Fissurectomy combined with anoplasty and injection of botulinum toxin in treatment of anterior chronic anal fissure with hypertonia of internal anal …

2010

Abstract BACKGROUND: In patients affected by anterior chronic anal fissure (CAAF) with hypertonia of the internal anal sphincter (IAS), the role of IAS hypertonia remains unclear. The aim of this study was to evaluate the efficacy of fissurectomy combined with advancement flap and IAS injection of botulinum toxin in healing the CAAF with hypertonia of IAS resistant to medical therapy. METHODS: Ten consecutive patients were enrolled. Anorectal manometry was performed preoperatively and at 6 months. CAAF with hypertonia was defined as those associated with maximum resting pressure (MRP) values higher than 85 mmHg. All patients underwent fissurectomy and anoplasty with advancement skin flap co…

AdultMalemedicine.medical_specialtyAdolescentPilot ProjectsInjections IntramuscularSurgical FlapsInternal anal sphincterCohort StudiesYoung AdultMuscle HypertoniamedicineHumanschronic anal fissureBotulinum Toxins Type ADefecationbusiness.industryAnorectal manometryGastroenterologyRecovery of FunctionMiddle AgedBotulinum toxinColorectal surgerySurgeryClinical trialTreatment OutcomeNeuromuscular AgentsAnesthesiaAnterior chronic anal fissure Fissurectomy Advancement flap Botulinum toxin.HypertoniaDefecationSurgeryFemaleFissure in Anomedicine.symptombusinessmedicine.drugAbdominal surgeryTechniques in coloproctology
researchProduct

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

2012

BACKGROUND: Some patients with severe asthma have recurrent asthma exacerbations associated with eosinophilic airway inflammation. Early studies suggest that inhibition of eosinophilic airway inflammation with mepolizumab-a monoclonal antibody against interleukin 5-is associated with a reduced risk of exacerbations. We aimed to establish efficacy, safety, and patient characteristics associated with the response to mepolizumab. METHODS: We undertook a multicentre, double-blind, placebo-controlled trial at 81 centres in 13 countries between Nov 9, 2009, and Dec 5, 2011. Eligible patients were aged 12-74 years, had a history of recurrent severe asthma exacerbations, and had signs of eosinophil…

AdultMalemedicine.medical_specialtyAdolescentPlacebo-controlled studyFevipiprantAntibodies Monoclonal HumanizedPlaceboLebrikizumabDrug Administration ScheduleLeukocyte CountYoung Adultchemistry.chemical_compoundDouble-Blind MethodReslizumabInternal medicineSecondary PreventionmedicineHumansAnti-Asthmatic AgentsPulmonary EosinophiliaChildGlucocorticoidsAgedAsthmaDose-Response Relationship Drugbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseBenralizumabAsthmaEosinophilsTreatment OutcomechemistryPhysical therapyDrug Therapy CombinationFemaleInterleukin-5businessMepolizumabmedicine.drugThe Lancet
researchProduct

Repetitive low-energy shock wave treatment for chronic lateral epicondylitis in tennis players.

2004

Background There is conflicting evidence regarding extracorporeal shock wave treatment for chronic tennis elbow. Hypothesis Treatment with repetitive low-energy extracorporeal shock wave treatment is superior to repetitive placebo extracorporeal shock wave treatment. Methods Seventy-eight patients enrolled in a placebo-controlled trial. All patients were tennis players with recalcitrant MRIconfirmed tennis elbow of at least 12 months’ duration. Patients were randomly assigned to receive either active low-energy extracorporeal shock wave treatment given weekly for 3 weeks (treatment group 1) or an identical placebo extracorporeal shock wave treatment (sham group 2). Main outcome measure was …

AdultMalemedicine.medical_specialtyAdolescentPlacebo-controlled studyPhysical Therapy Sports Therapy and RehabilitationWristPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawHand strengthLithotripsyTennis elbowmedicineHumansOrthopedics and Sports MedicineAgedPain Measurement030222 orthopedicsHand Strengthbusiness.industryEpicondylitisTennis Elbow030229 sport sciencesMiddle Agedmedicine.diseaseMagnetic Resonance ImagingSurgerymedicine.anatomical_structureTreatment OutcomeOrthopedic surgeryChronic DiseaseFemalebusinessThe American journal of sports medicine
researchProduct

A minor modification of Lichtenstein repair of primary inguinal hernia: postoperative discomfort evaluation.

2010

The aim of this study was to evaluate the usefulness of a modification of the Lichtenstein hernioplasty procedure by evaluating its impact on postoperative discomfort. From December 1999 to May 2006, the Lichtenstein inguinal hernioplasty was performed in 406 patients with noncomplicated unilateral inguinal hernia. During reconstruction, the mesh was fixed to the inguinal canal floor without stitching its upper margin to the internal oblique muscle. Control of postoperative pain proved to be satisfactory; 72 hours after surgery, 26.1 per cent of patients no longer felt any pain, whereas 54.4 per cent had slight pain without the need for painkillers; on Day 7, 92.8 per cent felt no pain at …

AdultMalemedicine.medical_specialtyAdolescentPostoperative paininguinal hernia repair Lichtenstein postoperative discomfortHernia InguinalQuality of lifemedicineHumansHerniaInguinal hernioplastyAgedPain MeasurementAged 80 and overPain PostoperativeChi-Square Distributionbusiness.industryChronic painRecovery of FunctionGeneral MedicineMiddle AgedSurgical Meshmedicine.diseaseInguinal canalSurgerySettore MED/18 - Chirurgia GeneraleInguinal herniaTreatment OutcomeSurgical meshmedicine.anatomical_structureAnesthesiaFemalebusiness
researchProduct

Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large mu…

2011

In β-thalassemia major (β-TM) patients, iron chelation therapy is mandatory to reduce iron overload secondary to transfusions. Recommended first line treatment is deferoxamine (DFO) from the age of 2 and second line treatment after the age of 6 is deferiprone (L1). A multicenter randomized open-label trial was designed to assess the effectiveness of long-term alternating sequential L1-DFO versus L1 alone iron chelation therapy in β-TM patients. Deferiprone 75 mg/kg 4 days/week and DFO 50 mg/kg/day for 3 days/week was compared with L1 alone 75 mg/kg 7 days/week during 5-year follow-up. A total of 213 thalassemia patients were randomized and underwent intention-to-treat analysis. Statisticall…

AdultMalemedicine.medical_specialtyAdolescentPyridonesThalassemiaClinical BiochemistryDeferoxamineIron Chelating AgentsGastroenterologyDrug Administration Schedulelaw.inventionchemistry.chemical_compoundYoung AdultRandomized controlled triallawInternal medicineMedicineHumansDeferiproneAdverse effectGenetics (clinical)Survival analysisbusiness.industryBiochemistry (medical)Serum ferritin levelbeta-ThalassemiaHematologyIron chelation therapymedicine.diseaseChelation TherapyDeferoxamineTreatment OutcomechemistryDrug Therapy CombinationFemalebusinessDeferiproneThalassemia Iron overload Iron chelation therapy Deferiprone (L1) Deferroxamine (DFO)medicine.drugFollow-Up StudiesHemoglobin
researchProduct

Auditory Mismatch Negativity and Repetition Suppression Deficits in Schizophrenia Explained by Irregular Computation of Prediction Error

2015

Background The predictive coding model is rapidly gaining attention in schizophrenia research. It posits the neuronal computation of residual variance (‘prediction error’) between sensory information and top-down expectation through multiple hierarchical levels. Event-related potentials (ERP) reflect cortical processing stages that are increasingly interpreted in the light of the predictive coding hypothesis. Both mismatch negativity (MMN) and repetition suppression (RS) measures are considered a prediction error correlates based on error detection and error minimization, respectively. Methods Twenty-five schizophrenia patients and 25 healthy controls completed auditory tasks designed to el…

AdultMalemedicine.medical_specialtyAdolescentSchizophrenia (object-oriented programming)lcsh:Medicine610Mismatch negativitySensory systemAudiologyElectroencephalography600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheitbehavioral disciplines and activitiesCorrelationYoung AdultEvent-related potentialmedicineHumansComputer Simulationlcsh:ScienceMultidisciplinarymedicine.diagnostic_testlcsh:RRepeated measures designMiddle AgedEvoked Potentials AuditorySchizophrenialcsh:QFemaleSchizophrenic PsychologyAnalysis of variancePsychologyResearch ArticlePLoS ONE
researchProduct

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

2014

Abstract Background Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen. Methods One hundred and thirteen patients admitted to 11 Italian IBD referral centres and treated with infliximab according to an intention to treat three-dose regimen were included. The co-primary endpoints were 3- and 12-month colectomy rate. The secondary end-points were the overall co…

AdultMalemedicine.medical_specialtyAdolescentSettore MED/12 - GASTROENTEROLOGIAmedicine.medical_treatmentUlcerative colitis;GastroenterologyDrug Administration ScheduleYoung AdultAdrenal Cortex HormonesInternal medicineHumansMedicineTreatment FailureAdverse effectColectomyInfliximab;AgedColectomyIntention-to-treat analysisbusiness.industryAnti-Inflammatory Agents Non-SteroidalGastroenterologyAntibodies MonoclonalGeneral MedicineMiddle Agedmedicine.diseaseUlcerative colitisInfliximabInfliximabRegimenTreatment OutcomeUlcerative colitisRelative riskCohortColitis UlcerativeFemalebusinessmedicine.drugJournal of Crohn's and Colitis
researchProduct

Increased sensitivity of the neuronal nicotinic receptor alpha-2 subunit causes familial epilepsy with nocturnal wandering and ictal fear

2006

Sleep has traditionally been recognized as a precipitating factor for some forms of epilepsy, although differential diagnosis between some seizure types and parasomnias may be difficult. Autosomal dominant frontal lobe epilepsy is characterized by nocturnal seizures with hyperkinetic automatisms and poorly organized stereotyped movements and has been associated with mutations of the α4 and β2 subunits of the neuronal nicotinic acetylcholine receptor. We performed a clinical and molecular genetic study of a large pedigree segregating sleep-related epilepsy in which seizures are associated with fear sensation, tongue movements, and nocturnal wandering, closely resembling nightmares and sleep …

AdultMalemedicine.medical_specialtyAdolescentSomnambulismMolecular Sequence DataMutation MissenseAutosomal dominant nocturnal frontal lobe epilepsyReceptors NicotinicBiologymedicine.disease_causeLigandsNicotinicArticleEpilepsyBIO/09 - FISIOLOGIAInternal medicineAcetylcholine; Adolescent; Adult; Aged; Aged 80 and over; Amino Acid Sequence; Epilepsy; Female; Humans; Ligands; Male; Molecular Sequence Data; Mutation Missense; Neurons; Pedigree; Receptors Nicotinic; Somnambulism; FearReceptorsmedicine80 and overGeneticsHumansIctalGenetics(clinical)Amino Acid SequenceGenetics (clinical)Acetylcholine receptorAgedAged 80 and overNeuronsMutationEpilepsySeizure typesFearmedicine.diseaseAcetylcholinePedigreeNicotinic acetylcholine receptorNicotinic agonistEndocrinologyMutationnAChR patch-clamp ADNFLE sleep-related epilepsy M1 TM1 ACh nicotineSettore MED/26 - NeurologiaFemaleMissense
researchProduct

Confirming the mechanisms behind cognitive-behavioural therapy effectiveness in chronic pain using structural equation modeling in a sample of patien…

2016

Objective To evaluate whether therapeutic mechanisms assumed to explain the effect of cognitive behavioural therapy (CBT) concerning temporomandibular symptoms are confirmed by structural equation modelling. Method Patients were randomly assigned to either an experimental group receiving CBT (N = 41) or a standard therapy control group (N = 31). Subjects were assessed before and after intervention using mediator variables hypothesized according to the CBT model, as well as outcome variables and other socio-demographic and clinical measures. Results The results confirm that the effect of treatment on pain intensity was partially mediated by distress, catastrophizing, perceived control, distr…

AdultMalemedicine.medical_specialtyAdolescentStructural equation modelinglaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled triallawIntervention (counseling)DistractionSurveys and QuestionnairesmedicineHumansYoung adultAgedCognitive Behavioral TherapyChronic painCognition030206 dentistryMiddle AgedTemporomandibular Joint Disordersmedicine.diseaseClinical PsychologyDistressTreatment OutcomePhysical therapyFemaleChronic PainPsychology030217 neurology & neurosurgeryClinical psychologyClinical psychologypsychotherapy
researchProduct

Cost-Utility Analysis Applied to the Treatment of Burn Patients in a Specialized Center

2007

Objective To discover the total costs and quality of life of burn patients in a specialist center classified by diagnosis-related groups (DRGs). Design Prospective study of 5-year follow-up from January 1, 1997, through December 31, 2001. Setting Burn Center of Valencia. Patients A total of 898 patients treated at the Burn Center of Valencia. Main Outcome Measures Hospital, extrahospital, caregiving, labor, and social costs of the burn patients grouped by DRG (code 457: extensive burns without operating room procedure; code 458: nonextensive burns with skin graft; code 459: nonextensive burns with wound debridement or other operating room procedure; code 460: nonextensive burns without oper…

AdultMalemedicine.medical_specialtyAdolescentTotal costBurn UnitsAllied Health PersonnelQuality of lifeOutcome Assessment Health CareHealth caremedicineHumansChildProspective cohort studyDiagnosis-Related Groupshealth care economics and organizationsAgedCost–utility analysisCost–benefit analysisbusiness.industryBurn centerHealth Care CostsLength of StayMiddle AgedSurgeryHospitalizationSpainCosts and Cost AnalysisQuality of LifeLife expectancyFemaleSurgeryBurnsbusinessArchives of Surgery
researchProduct